Two post-doctoral research positions are available in AI-inspired drug design in the Biomedical Computing Group headed by Professor Jagath Rajapakse at Nanyang Technological University, Singapore, for a period of three years starting from 1 July 2025. The project investigates the design of biologics (peptides and antibodies) as anticancer therapeutic agents by using eXplainable AI (XAI) and generative AI (genAI). First, we build predictive AI models such as large language models (LLM) for predicting binding affinities of biologics. Second, we use XAI approaches such as integrated gradients for identifying the features of predictive models and the mechanism of action of biologics. Third, using these features as constraints, we will use genAI techniques such as LLM and diffusion models to generate biologics with anti-cancer properties. The candidate will develop necessary predictive AI, XAI and genAI methods for design of anti-cancer biologics.